ANCA-Associated Vasculitis after Moderna COVID-19 Vaccination

ANCA-Associated Vasculitis after Moderna COVID-19 Vaccination

We experienced a case of myeloperoxidase antineutrophil cytoplasmic antibody (MPO-ANCA)-associated vasculitis after Moderna COVID-19 vaccination. An 82-year-old woman developed pyrexia and general malaise one month after her third booster vaccine, and the symptoms persisted. Blood testing revealed i...

Full description

Saved in:

Bibliographic Details
Main Authors:	Shiko Gen, Takanori Iwai, Sayuri Ohnari, Kanako Nobe, Naofumi Ikeda
Format:	Article
Language:	English
Published:	Wiley 2023-01-01
Series:	Case Reports in Nephrology
Online Access:	http://dx.doi.org/10.1155/2023/4906876
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

RECURRENT ANCA-ASSOCIATED VASCULITIS AFTER KIDNEY ALLOTRANSPLANTATION
by: N. F. Frolova, et al.
Published: (2016-03-01)

A Case of Neurosarcoidosis-Induced Syndrome of Inappropriate Secretion of Antidiuretic Hormone Diagnosed with Neuroendoscopy
by: Shiko Gen, et al.
Published: (2018-01-01)

Case report: Testicular manifestation of ANCA vasculitis
by: Noah J. Sandel, et al.
Published: (2025-03-01)

Thrombosis risk factors in ANCA-associated vasculitis
by: E. N. Kharlamova, et al.
Published: (2023-04-01)

Diagnosing and Treating ANCA-Associated Vasculitis within the COVID-19 Era: A Challenging Case Report
by: Erjola Likaj, et al.
Published: (2025-01-01)

Comparison of different ANCA detection methods in a predominantly MPO-ANCA-associated vasculitis cohort
by: Yasuhiro Katsumata, et al.
Published: (2025-01-01)

The Utility of Bronchoscopy in Hydralazine-Induced ANCA-Associated Vasculitis
by: Atulya Aman Khosla, et al.
Published: (2023-01-01)

Treatment With Avacopan in ANCA–Associated Vasculitis With Kidney Involvement
by: Duvuru Geetha, et al.
Published: (2025-08-01)

Endothelial dysfunction of vessels at ANCA-associated systemic vasculitis
by: L. V. Sedaia, et al.
Published: (2015-08-01)

Burden of coronary artery calcification in ANCA-associated vasculitis
by: Claire Cook, et al.
Published: (2025-01-01)

Covid-19 in a patient with ANCA-associated systemic vasculitis, receiving anti-B cell therapy (rituximab)
by: T. V. Beketova, et al.
Published: (2020-09-01)

PROBLEMS IN THE DIAGNOSIS AND TREATMENT OF ANCA-ASSOCIATED SYSTEMIC VASCULITIS: IN THE FOCUS OF ANCA-NEGATIVE PAUCI-IMMUNE GLOMERULONEPHRITIS
by: T. V. Beketova, et al.
Published: (2016-12-01)

Practical Management of ANCA-Associated Vasculitis: A Clinician’s Perspective
by: Hannah L. Stacey, et al.
Published: (2024-12-01)

THE ONSET OF ANCA-ASSOCIATED SYSTEMIC VASCULITIS MASKING RHEUMATOID ARTHRITIS
by: N. F. Frolova, et al.
Published: (2016-02-01)

Exploring ANCA Pathogenicity in Ulcerative Colitis: A Case Report Highlighting the Risk of Progression to ANCA-Associated Vasculitis
by: Abir Hamid, et al.
Published: (2025-05-01)

Review of guideline for the management of ANCA-associated vasculitis, presented in 2021 by the American College of Rheumatology/Vasculitis Foundation
by: T. V. Beketova, et al.
Published: (2021-12-01)

Vasculitis After a Vaccine: Rare Adverse Reaction Following a COVID-19 Vaccine
by: Prutha Pathak, et al.
Published: (2023-10-01)

The plasma proteome reveals distinct signaling pathways associated with PR3-ANCA positive and MPO-ANCA positive vasculitis
by: Erik Hellbacher, et al.
Published: (2025-06-01)

ANCA Vasculitis and Hemophagocytic Lymphohistiocytosis following a Fecal Microbiota Transplant
by: Adam Amlani, et al.
Published: (2018-01-01)

“Fleshy” Skin Cellulitis: A Triggering Factor for ANCA Associated Vasculitis
by: Sim Chun Yang, et al.
Published: (2020-02-01)

Successful total hip arthroplasty in patients with anca-associated systemic vasculitis
by: T. V. Beketova, et al.
Published: (2019-11-01)

“Fleshy” Skin Cellulitis: A Triggering Factor for ANCA Associated Vasculitis
by: Sim Chun Yang, et al.
Published: (2020-02-01)

New ACR/EULAR 2022 classification criteria for ANCA-associated vasculitis
by: T. V. Beketova
Published: (2023-10-01)

Prospective study of complications and sequelae of glucocorticoid therapy in ANCA-associated vasculitis
by: Bernhard Hellmich, et al.
Published: (2024-02-01)

Impact of NF-κB and reactive oxygen species on intracellular BAFF/APRIL expression in ANCA-associated vasculitis: focusing on the effect of resveratrol
by: Yasuhiro Shimojima, et al.
Published: (2025-06-01)

A case report of metastatic renal cell carcinoma and ANCA associated vasculitis
by: Maddison Taylor, et al.
Published: (2025-07-01)

Evaluating Avacopan in the Treatment of ANCA-Associated Vasculitis: Design, Development and Positioning of Therapy
by: van Leeuwen JR, et al.
Published: (2025-01-01)

Myocardial infarction in ANCA-associated vasculitis: a population-based cohort study
by: Moman Aladdin Mohammad, et al.
Published: (2025-04-01)

Medium-vessel vasculitis following COVID-19 moderna (mRNA-1273) vaccination and the utility of PET-CT as a diagnostic tool: a case report
by: Martin H. Cherk, et al.
Published: (2025-04-01)

ANCA-related vasculitis incidence and features before and during the COVID-19 pandemic in Los Angeles, Biobio Province, Chile: an observational retrospective analysis
by: Daniel Enos, et al.
Published: (2025-06-01)

A case of cutaneous small vessel vasculitis after the seventh dose of COVID‐19 vaccination
by: Hiroshi Sato, et al.
Published: (2025-03-01)

Goodpasture’s Syndrome and p-ANCA Associated Vasculitis in a Patient of Silicosiderosis: An Unusual Association
by: Amanjit Bal, et al.
Published: (2014-01-01)

Risk factors of poor outcomes in ANCA-associated vasculitis: a single-center study
by: Axi Age, et al.
Published: (2025-12-01)

Propylthiouracil-induced ANCA-associated vasculitis complicated by granulocytopenia and hemophagocytosis: a case report
by: Huilin Zhou, et al.
Published: (2025-04-01)

Hydralazine-Induced ANCA Vasculitis Presenting With Pericarditis: A Novel Case and Literature Review
by: Ahmed Sami Hammami, et al.
Published: (2025-01-01)

Comorbid infections in patients with ANCA-associated systemic vasculitis: a prospective cohort study
by: M. A. Litvinova, et al.
Published: (2025-04-01)

Integrated bioinformatic analysis of the shared molecular mechanisms between ANCA-associated vasculitis and atherosclerosis
by: Xun Hu, et al.
Published: (2024-12-01)

Imbalance of Circulatory T Follicular Helper and T Follicular Regulatory Cells in Patients with ANCA-Associated Vasculitis
by: Ying Xu, et al.
Published: (2019-01-01)

The course and outcomes of COVID-19 in patients with ANCA-associated systemic vasculitis, receiving biological therapy (Rituximab, Mepolizumab): The results of the first 8 months of the pandemic
by: T. V. Beketova, et al.
Published: (2021-03-01)

Leukocytoclastic Vasculitis following the First Dose of the Elasomeran COVID-19 Vaccination
by: Jarett J. Casale, et al.
Published: (2022-01-01)